Skip to main content
Clinical Trials/NCT05065281
NCT05065281
Completed
Not Applicable

Responding to Elder Abuse in GERiAtric Care Educational Intervention for Healthcare Providers: a Non-randomised Stepped Wedge Trial.

Region Östergötland3 sites in 1 country554 target enrollmentSeptember 16, 2021
ConditionsHealthy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
Region Östergötland
Enrollment
554
Locations
3
Primary Endpoint
Change between baseline and follow up concerning asking questions about abuse, as reported in the questionnaire REAGERA-P
Status
Completed
Last Updated
last year

Overview

Brief Summary

The prevalence of elder abuse has been reported between 10-15% in international studies. Elder abuse may include both physical, emotional, sexual and financial abuse as well as neglect and it occurs at the hand of both professionals and family members, including adult children and intimate partners. Elder abuse has been associated with psychological ill-health, disability, increased hospitalization, emergency department use and admission to nursing facilities. Elder abuse is however often unknown to health care providers. Older adults are hesitant to disclose abuse and health care providers are often reluctant to ask questions.

In this study an interactive educational model for health care professionals about elder abuse will be tested. The model consist of theoretical lectures, brief films showing patient encounters, group discussions and forum play, a form of participatory theater. Both group discussions and forum play will be using case scenarios as a cornerstone.

The validated questionnaire REAGERA-P will be used for self-reported measures

Detailed Description

Please refer to the uploaded study protocol for a detailed description of the study.

Registry
clinicaltrials.gov
Start Date
September 16, 2021
End Date
November 18, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Johanna Simmons

Principal Investigator

Region Östergötland

Eligibility Criteria

Inclusion Criteria

  • Employee at one of the clinics participating in the trial
  • Work tasks involves direct patient contact, at least part time
  • Participation at the training sessions

Exclusion Criteria

  • Only administrative work and no direct patient contact
  • Not participating at the training session

Outcomes

Primary Outcomes

Change between baseline and follow up concerning asking questions about abuse, as reported in the questionnaire REAGERA-P

Time Frame: Baseline, 6 month follow up, 12 month follow up

Self-report measure of asking older patients about abusive experience. Will be measure both as a dichotomous value (have ever asked questions during the last 6 months) as well as a frequency measure where participants report how often they have asked patients questions about abuse during the last 6 months (on a scale from 0 to 10 or more)

Secondary Outcomes

  • Change between baseline and follow up concerning perceived ability to ask questions about abuse, as reported in REAGERA-P(Baseline, Immediate post-intervention, 6 month follow up, 12 month follow up)
  • Change between baseline and follow up concerning perceived preparedness to manage cases of elder abuse, as reported in REAGERA-P(Baseline, Immediate post-intervention (number 1and 2), 6 months follow up, 12 months follow up)
  • Change between baseline and follow up concerning awareness of elder abuse and sense of responsibility for identifying victims, as reported in the questionnaire REAGERA-P(Baseline, Immediate post-intervention (number 2), 6 month follow up, 12 month follow up)
  • Change between baseline and follow up concerning level of awareness of abuse in contact with patients, as reported in the questionnaire REAGERA-P(Baseline, 6 or 12 month follow up (different for different clusters))
  • Change between baseline and follow up concerning preparedness at the clinic to care for older adults subjected to abuse, as reported in REAGERA-P(Baseline, 6 months follow up, 12 months follow up)

Study Sites (3)

Loading locations...

Similar Trials